277. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. Short- and long-term attributable cost of Clostridium difficile -associated disease in non-surgical patients. Clin Infect Dis. 2008;46(4):497-504. 278. Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of Clostridium difficile -associated disease in adult hospitalized patient population. Infect Control Hosp Epidemiol . 2008;29(9):823-828. 279. Lipp MJ, Nero DC, Callahan MA. Impact of hospital-acquired Clostridium difficile. J Gastroenterol Hepatol . 2012;27(11):1733-1737. 280. Centers for Disease Control and Prevention. 2021 Annual Report for the Emerging Infections Program for Clostridium difficile Infection. Available at https://archive.cdc.gov/www_cdc_gov/hai/eip/Annual-CDI-Report-2021.html. Last accessed January 15, 2025. 281. Guh AY, Winston LG, Johnston H, et al. Trends in U.S. burden of Clostridioides difficile infection and outcomes. N Engl J Med . 2020;382(14):1320- 1330. 282. Leclair M-A, Allard C, Lesur O, Pépin J. Clostridium difficile infection in the intensive care unit. J Intensive Care Med . 2010;25(1):23-30. 283. US Food and Drug Administration. FDA in Brief: FDA Warns About Potential Risk of Serious Infections Caused By Multi-Drug Resistant Organisms Related to the Investigational Use of Fecal Microbiota for Transplantation. Available at: https://www.fda.gov/news-events/fda- brief/fda-brief-fda-warns-about-potential-risk-serious-infections-caused-multi-drug-resistant-organisms. Last accessed January 15, 2025. 284. US Food and Drug Administration. Update to March 12, 2020 safety alert regarding use of fecal microbiota for transplantation and risk of serious adverse events likely due to transmission of pathogenic organisms. Available at: https://www.fda.gov/vaccines-blood-biologics/safety- availability-biologics/update-march-12-2020-safety-alert-regarding-use-fecal-microbiota-transplantation-and-risk-serious. Last accessed January 15, 2025. 285. Birch T, Golan Y, Rizzardini G, et al. Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infection. J Antimicrob Chemother . 2018;73:2524-2528. 286. Lexicomp Online. Available at https://online.lexi.com. Last accessed January 15, 2025. 287. Halsey J. Current and future treatment modalities for Clostridium difficile -associated disease. Am J Health Syst Pharm . 2008;65(8):705-715. 288. Pillai A, Nelson R. Probiotics for treatment of Clostridium difficile -associated colitis in adults. Cochrane Database Syst Rev . 2008;(1):CD004611. 289. Haley RW, Quade D, Freeman HE, Bennett JV. Study on the efficacy of nosocomial infection control (SENIC Project): summary of study design. Am J Epidemiol . 1980;111(5):472-485. 290. Haley RW, Culver DH, White JW, et al. The efficacy of infection surveillance and control programs in preventing nosocomial infections in U.S. hospitals. Am J Epidemiol . 1985;121(2):182-205. 291. Association for Professionals in Infection Control and Epidemiology. Infection Prevention and You. Available at http://www.apic.org/ Resource_/TinyMceFileManager/IP_and_You/IPandYou_SmallFlyer_download_hiq.pdf. Last accessed January 15, 2025. 292. Kaye KS, Engemann JJ, Fulmer EM, Clark CC, Noga EM, Sexton DJ. Favorable impact of an infection control network on nosocomial infection rates in community hospitals. Infect Control Hosp Epidemiol . 2006;27(3):228-232. 293. Anderson DJ, Miller BA, Chen LF, et al. The network approach for prevention of healthcare-associated infections: long-term effect of participation in the Duke Infection Control Outreach Network. Infect Control Hosp Epidemiol . 2011;32(4):315-322. 294. Centers for Disease Control and Prevention. Clean Hands. Clinical Safety: Hand Hygiene for Healthcare Workers. Available at https://www. cdc.gov/clean-hands/hcp/clinical-safety/index.html#cdc_clinical_safety_best_practices_recomm-recommendations. Last accessed January 15, 2025. 295. Erasmus V, Daha TJ, Brug H, et al. Systematic review of studies on compliance with hand hygiene guidelines in hospital care. Infect Control Hosp Epidemiol . 2010;31(3):283-294. 296. Johnson PDR, Rhea M, Burrell LJ, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust . 2005;183(10):509-514. 297. Gordin FM, Schultz ME, Huber RA, Gill JA. Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol- based handrub. Infect Control Hosp Epidemiol . 2005;26(7):650-653. 298. Gould DJ, Moralejo D, Drey N, Chudleigh JH. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev . 2010;(9):CD005186. 299. Gould DJ, Moralejo D, Drey N, Chudleigh JH, Taljaard M. Interventions to improve hand hygiene compliance in patient care. Cochrane Database Syst Rev . 2017;9(9):CD005186. 300. The Joint Commission. Measuring Hand Hygiene Adherence . Overcoming the Challenges . Oakbrook Terrace, IL: The Joint Commission; 2009. 301. Salgado CD, Giannetta ET, Hayden FG, Farr BM. Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians. Infect Control Hosp Epidemiol . 2004;25(11):923-928. 302. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination on health-care workers on mortality of elderly people in long-term care: a randomized controlled trial. Lancet . 2000;355(9198):93-97. 303. Centers for Disease Control and Prevention. Clinical Guidance for Influenza Vaccination. Available at https://www.cdc.gov/flu/hcp/vax- summary/index.html. Last accessed January 15, 2025. 304. Pearson ML, Bridges CB, Harper SA. Influenza vaccination of health-care personnel. MMWR . 2006;55(RR02):1-16. 305. Nichol K. Improving influenza vaccination rates among adults. Cleve Clin J Med . 2006;73(11):1009-1015. 306. The Joint Commission. Re Report Issue 3: Influenza Vaccination. Available at https://www.jointcommission.org/standards/r3-report/r3-report- issue-3---influenza-vaccination/. Last accessed January 15, 2025. 307. Bell J, Meng L, Barbre K, et al. Influenza and COVID-19 vaccination coverage among health care personnel – National Healthcare Safety Network, United States, 2023-24 respiratory virus season. MMWR . 2024;73(43):966-972.
Powered by FlippingBook